CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 134 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2017. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $458,000 | +15.9% | 160,000 | 0.0% | 0.05% | +2.1% |
| Q2 2017 | $395,000 | -31.7% | 160,000 | 0.0% | 0.05% | -39.0% |
| Q1 2017 | $578,000 | +2.1% | 160,000 | 0.0% | 0.08% | -33.6% |
| Q4 2016 | $566,000 | -12.4% | 160,000 | 0.0% | 0.12% | -0.9% |
| Q3 2016 | $646,000 | -8.0% | 160,000 | 0.0% | 0.12% | -11.4% |
| Q2 2016 | $702,000 | +16.0% | 160,000 | 0.0% | 0.13% | +20.0% |
| Q1 2016 | $605,000 | – | 160,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |